Chemomab Therapeutics Ltd. enterprise value

The Enterprise Value as of November 2026 (TTM) for Chemomab Therapeutics Ltd. (CMMB) is 2.70M

According to Chemomab Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.70M. This represents a change of -61.77% compared to the average of 7.05M of the last 4 quarters.

Chemomab Therapeutics Ltd. (CMMB) Historical Enterprise Value (quarterly & annually)

How has CMMB Enterprise Value performed in the past?

The mean historical Enterprise Value of Chemomab Therapeutics Ltd. over the last ten years is 23.91M. The current 2.70M Enterprise Value has changed -88.72% with respect to the historical average. Over the past ten years (40 quarters), CMMB's Enterprise Value was at its highest in in the December 2018 quarter at 149.32M. The Enterprise Value was at its lowest in in the March 2023 quarter at -17074159.78.

Chemomab Therapeutics Ltd. (CMMB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chemomab Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chemomab Therapeutics Ltd. (CMMB) Average Enterprise Value

How has CMMB Enterprise Value performed in the past?

The current Enterprise Value of Chemomab Therapeutics Ltd. (CMMB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chemomab Therapeutics Ltd. (CMMB) Enterprise Value vs. Peers

How is CMMB’s Enterprise Value compared to its peers?

Chemomab Therapeutics Ltd.’s Enterprise Value is greater than Kazia Therapeutics Ltd ADR (-50025141.26), less than Ocean Biomedical, Inc. (16.38M), greater than Theriva Biologics, Inc. (-161228.00), greater than PMGC Holdings Inc. (-2460091.00), greater than Can-Fite BioPharma Ltd. (752.54K), less than BioVie Inc. (3.37M), greater than XORTX Therapeutics Inc. (860.04K), less than InMed Pharmaceuticals Inc. (6.71M), less than CERo Therapeutics Holdings, Inc. (7.92M), greater than Galmed Pharmaceuticals Ltd. (1.87M),

Build a custom stock screener for Chemomab Therapeutics Ltd. (CMMB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chemomab Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chemomab Therapeutics Ltd. (CMMB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chemomab Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.